Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_assertion type Assertion NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_head.
- NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_assertion description "[We performed gene expression profile (GEP) analysis of six AILT, six anaplastic large cell lymphomas (ALCL), 28 PTCL-unspecified (PTCL/U), and 20 samples of normal T lymphocytes (including CD4(+), CD8(+), and activated and resting subpopulations), aiming to (a) assess the relationship of AILT with other PTCLs, (b) establish the relationship between AILT and normal T-cell subsets, and (c) recognize the cellular programs deregulated in AILT possibly looking for novel potential therapeutic targets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_provenance.
- NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_assertion evidence source_evidence_literature NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_provenance.
- NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_assertion SIO_000772 18006812 NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_provenance.
- NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_assertion wasDerivedFrom befree-20140225 NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_provenance.
- NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_assertion wasGeneratedBy ECO_0000203 NP579247.RAvXlTJFpVc7G2My3VFASlkxent7o0zEPa_D_EKQ9aQao130_provenance.